NEW YORK, March 12, 2013 - vb-news.net, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Yum! Brands, American International Group Inc, Johnson & Johnson.
China Sales at established restaurants of KFC parent Yum! Brands, Inc.(NYSE:YUM) rose an unexpected 2 percent in February. Analysts had expected an 8.7 percent drop in sales.
Is YUM a Buy After Today’s Solid News? Find Out Here http://vbtrendreport.com/aw/?code=YUM
The first-quarter same-restaurant sales in China fell 20 percent, lower than Yum’s prior forecast of a 25 percent fall. In December, Yum had seen fewer diners after news reports of chemical residue found in the restaurant’s chicken supply and the subsequent government investigations.
Yum was not fined. The company apologized for the chicken incident, and promised not to deal with smaller poultry suppliers that have not modernized their operations and also to enforce strict food safety procedures.
The stock zoomed 2.50 percent to $69.57.
Meanwhile, two groups of American International Group Inc(NYSE:AIG) shareholders won class-action status from a federal judge on Monday in a lawsuit filed by former CEO Maurice "Hank" Greenberg over losses caused by the U.S. government's bailout of the insurer.
U.S. Court of Federal Claims Judge Thomas Wheeler also appointed Greenberg's lawyer, David Boies, as lead counsel for the classes. Greenberg's Starr International Co, once AIG's largest shareholder had sued the United States government in 2011 saying that by taking a 79.9 percent AIG stake and then conducting a reverse stock split without allowing existing shareholders to vote, the government had violated the 5th Amendment of the U.S. Constitution.
How Should Investors Trade AIG After The Recent Momentum? Get Free Trend Analysis Here http://vbtrendreport.com/aw/?code=AIG
One class includes AIG shareholders as of September 22, 2008 while the other includes shareholders as of June 30, 2009 who were denied a chance to vote on the reverse stock split.
The spokesman of the U.S. Department of Justice, Charles Miller, refused to comment.
AIG had decided in January not to be party to Greenberg's lawsuit, after Congress and voters expressed their anger over the possibility that AIG would be suing its rescuer.
A part of the Johnson & Johnson(NYSE:JNJ) family of companies, Janssen Cilag International NV has made an announcement recently that the company has submitted a Marketing Authorisation Application (MAA) in the EU for its fixed-dose combination of canagliflozin and metformin (immediate release) for the treatment of type II diabetes patients. Once this fixed dose combination is approved, it would provide the patients an option for convenient treatment.
Is JNJ a Buy At New Highs? Find Out Here http://vbtrendreport.com/aw/?code=JNJ
Johnson & Johnson is seeking for approval both in the United Kingdom as well as in the United States. At the annual meeting of the European Association for the Study of Diabetes, the company had presented data of phase III on canagliflozin. It also presented results from the CANagliflozin cardioVascular Assessment Study. The study has taken into consideration 4,330 type II diabetes patients (adults) who are at higher risk for cardiovascular disease.
vb-news.net’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by vb-news.net is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vb-news.net does expect that investors will buy and sell securities based on information assembled and presented in vb-news.net. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA
Leave a comment...